«Near Drowning

Below is an extended Near Drowning patents listing. Click here to return to the Near Drowning main in depth entry.

Patents :
US Patent No.	Title
6683101	Bicyclic cyclohexylamines and their use as NMDA receptor antagonists
6855340	Copper lowering treatment of inflammatory and fibrotic diseases
6858223	Compositions comprising phenylaminothiophenacetic acid derivatives for the treatment of acute or adult respiratory distress syndrome (ARDS) and infant respiratory distress syndrome (IRDS)
6887845	Polypeptoid pulmonary surfactants
6919377	Cyclohexylamine derivative as subtype selective NMDA receptor antagonists
6935334	Enhancing therapeutic effectiveness of nitric oxide inhalation
6964638	Measuring cognitive impairment
6965012	Flint polypeptide analogs
6998410	Compositions
7005504	Antibody fragment-peg conjugates
7022671	Surfactant protein C esters
6835814	Protease resistant flint analogs
6828341	Cyclohexylamine derivatives as subtype selective N-Methyl-D-Aspartate antagonists
6821256	Non-alternating beat-to-beat fluctuations in T wave morphology
6693077	Keratinocyte growth factor-2
6693111	Indole-2,3-dione-3-oxime derivatives
6727260	Inhibitors of proton-gated cation channels and their use in the treatment of ischaemic disorders
6730692	Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
6765022	Cyclohexylamine derivatives as subtype selective nmda receptor antagonists
6765991	Emergency telecommunication device
6787309	Alterations in the long QT syndrome genes KVLQT1 and SCN5A and methods for detecting same
6794402	Bicyclic cyclohexylamines and their use as NMDA receptor antagonists
6802812	Noninvasive optical sensor for measuring near infrared light absorbing analytes
6805519	Garment integrated multi-chambered personal flotation device or life jacket
7053176	Combination of C1-INH and lung surfactant for the treatment of respiratory disorders
7122636	Antibody fragment-polymer conjugates and uses of same
7297099	Use of osteopontin for the treatment and/or prevention of neurologic diseases
7297546	Methods for identifying and monitoring patients at risk for systemic inflammatory conditions, methods for selecting treatments for these patients and apparatus for use in these methods
7304031	Methods and means for producing proteins with predetermined post-translational modifications
7309687	Methods for treatment and prevention of neuromuscular and muscular conditions by peripherally administered erythropoietin
7319090	Methods of treating cerebral ischemia
7326683	Treatment of membrane-associated diseases and disorders using lantibiotic containing compositions
7330123	Sonar based drowning monitor
7345019	Modulation of excitable tissue function by peripherally administered erythropoietin
7381733	Tropane derivatives having dopamine reuptake inhibitor activity for the treatment of ischemic diseases
7410941	Methods for treatment of neurodegenerative conditions by peripherally administered erythropoietin
7288653	Inhibitors of proton-gated cation channels and their use in the treatment of ischaemic disorders
7282511	Isatine derivatives with neurotrophic activity
7268123	Derivatives of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl]phosphonic acid and methods of making them
7150737	Methods and apparatuses for navigating the subarachnoid space
7153828	Use of heregulin as a growth factor
7160166	Underwater flotation safety device
7173009	Surfactant protein C esters
7214776	Antibody fragment-polymer conjugates and uses of same
7217687	Use of osteopontin for the treatment and/or prevention of neurologic diseases
7232667	Keratinocyte growth factor-2 polynucleotides
7238664	Composition comprising a pulmonary surfactant and a PDE5 inhibitor for the treatment of lung diseases
7247317	Compositions comprising phenylaminothiophenacetic acid derivatives for the treatment of acute or adult respiratory distress syndrome (ARDS) and infant respiratory distress syndrome (IRDS)
7253153	Derivatives of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl] phosphonic acid and methods of use thereof
7416741	Copper lowering treatment of inflammatory and fibrotic diseases

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.